Align Technology [ALGN] vs ResMed [RMD] Detailed Stock Comparison

Align Technology

NASDAQ

ResMed

NYSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Align Technology wins in 9 metrics, ResMed wins in 10 metrics, with 0 ties. ResMed appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Align Technology	ResMed	Better
P/E Ratio (TTM)	25.27	30.29	Align Technology
Price-to-Book Ratio	2.77	7.07	Align Technology
Debt-to-Equity Ratio	3.14	14.27	Align Technology
PEG Ratio	0.73	28.02	Align Technology
EV/EBITDA	11.78	22.50	Align Technology
Profit Margin (TTM)	11.04%	27.22%	ResMed
Operating Margin (TTM)	16.10%	33.87%	ResMed
EBITDA Margin (TTM)	16.10%	33.87%	ResMed
Return on Equity	11.41%	25.86%	ResMed
Return on Assets (TTM)	6.50%	14.02%	ResMed
Free Cash Flow (TTM)	$622.65M	$1.65B	ResMed
Dividend Yield	N/A	0.63%	N/A
1-Year Return	-36.07%	29.60%	ResMed
Price-to-Sales Ratio (TTM)	2.73	8.20	Align Technology
Enterprise Value	$9.42B	$41.86B	ResMed
EV/Revenue Ratio	2.38	8.13	Align Technology
Gross Profit Margin (TTM)	69.94%	60.84%	Align Technology
Revenue per Share (TTM)	$54	$35	Align Technology
Earnings per Share (Diluted)	$5.92	$9.52	ResMed
Beta (Stock Volatility)	1.61	0.77	ResMed

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Align Technology vs ResMed Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Align Technology	6.33%	5.01%	-22.93%	-13.35%	-21.58%	-28.26%
ResMed	1.87%	3.10%	9.85%	19.65%	27.90%	28.56%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Align Technology	-36.07%	-40.75%	-50.24%	161.17%	817.61%	2,197.54%
ResMed	29.60%	32.82%	62.98%	459.81%	860.22%	1,521.03%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Align Technology (ALGN): View Full Stock Overview

ResMed (RMD): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Align Technology vs ResMed

Metric	ALGN	RMD
Market Information
Market Cap i	$10.84B	$42.22B
Market Cap Category	Large cap	Large cap
10 Day Avg. Volume i	1,598,019	918,860
90 Day Avg. Volume i	2,040,930	1,072,643
Last Close	$149.57	$293.73
52 Week Range	$127.70 - $262.87	$199.92 - $293.81
% from 52W High	-43.10%	-0.03%
All-Time High	$737.45 (Sep 20, 2021)	$301.34 (Sep 06, 2021)
% from All-Time High	-79.72%	-2.53%
Growth Metrics
Quarterly Revenue Growth	-0.02%	0.10%
Quarterly Earnings Growth	0.29%	0.30%
Financial Health
Profit Margin (TTM) i	0.11%	0.27%
Operating Margin (TTM) i	0.16%	0.34%
Return on Equity (TTM) i	0.11%	0.26%
Debt to Equity (MRQ) i	3.14	14.27
Cash & Liquidity
Book Value per Share (MRQ)	$53.98	$40.77
Cash per Share (MRQ)	$12.43	$8.26
Operating Cash Flow (TTM) i	$731.07M	$1.75B
Levered Free Cash Flow (TTM) i	$676.43M	$1.21B
Dividends
Last 12-Month Dividend Yield i	N/A	0.63%
Last 12-Month Dividend i	N/A	$1.59

Valuation & Enterprise Metrics Analysis: Align Technology vs ResMed

Metric	ALGN	RMD
Price Ratios
P/E Ratio (TTM) i	25.27	30.29
Forward P/E i	14.58	28.02
PEG Ratio i	0.73	28.02
Price to Sales (TTM) i	2.73	8.20
Price to Book (MRQ) i	2.77	7.07
Market Capitalization
Market Capitalization i	$10.84B	$42.22B
Enterprise Value i	$9.42B	$41.86B
Enterprise Value Metrics
Enterprise to Revenue i	2.38	8.13
Enterprise to EBITDA i	11.78	22.50
Risk & Other Metrics
Beta i	1.61	0.77
Book Value per Share (MRQ) i	$53.98	$40.77

Financial Statements Comparison: Align Technology vs ResMed

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	ALGN	RMD
Revenue/Sales i	$979.26M	$1.35B
Cost of Goods Sold i	$299.15M	$527.93M
Gross Profit i	$680.11M	$820.07M
Research & Development i	$97.20M	$86.44M
Operating Income (EBIT) i	$135.28M	$456.57M
EBITDA i	$178.60M	$532.89M
Pre-Tax Income i	$140.44M	$458.05M
Income Tax i	$47.21M	$78.35M
Net Income (Profit) i	$93.23M	$379.71M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	ALGN	RMD
Cash & Equivalents i	$873.01M	$1.21B
Total Current Assets i	$2.40B	$3.51B
Total Current Liabilities i	$1.99B	$1.02B
Long-Term Debt i	$86.49M	$811.41M
Total Shareholders Equity i	$3.79B	$5.97B
Retained Earnings i	$2.39B	$6.08B
Property, Plant & Equipment i	$1.38B	$288.62M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	ALGN	RMD
Operating Cash Flow i	$139.21M	$441.40M
Capital Expenditures i	$-25.29M	$-30.59M
Free Cash Flow i	$27.39M	$504.99M
Debt Repayment i	N/A	$-5.00M
Common Stock Repurchase i	$-201.09M	$-100.01M

Short Interest & Institutional Ownership Analysis

Metric	ALGN	RMD
Shares Short i	2.74M	9.02M
Short Ratio i	1.83	9.55
Short % of Float i	0.05%	0.07%
Average Daily Volume (10 Day) i	1,598,019	918,860
Average Daily Volume (90 Day) i	2,040,930	1,072,643
Shares Outstanding i	73.85M	146.39M
Float Shares i	67.59M	145.51M
% Held by Insiders i	0.07%	0.01%
% Held by Institutions i	0.95%	0.65%

Dividend Analysis & Yield Comparison: Align Technology vs ResMed

Metric	ALGN	RMD
Last 12-Month Dividend i	N/A	$1.59
Last 12-Month Dividend Yield i	N/A	0.63%
3-Year Avg Annual Dividend i	N/A	$1.60
3-Year Avg Dividend Yield i	N/A	0.23%
3-Year Total Dividends i	N/A	$4.79
Ex-Dividend Date	N/A	Feb 13, 2025

Align Technology [ALGN] vs ResMed [RMD] Detailed Stock Comparison